Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Operating Expenses | 3,200 | 5,629 | 2,528 | 3,545 | 5,379 |
| Operating Income | -3,200 | -5,629 | -2,528 | -3,545 | -5,379 |
| Interest Expense | 3 | 2 | 5 | 7 | 7 |
| Other Income | 26 | 25 | 2 | 7 | 11 |
| Pre-tax Income | -3,176 | -5,606 | -2,531 | -3,545 | -5,375 |
| Net Income Continuous | -3,176 | -5,606 | -2,531 | -3,545 | -5,375 |
| Net Income | $-3,176 | $-5,606 | $-2,531 | $-3,545 | $-5,375 |
| EPS Basic Total Ops | 15,986.17 | -153.20 | -4,049.20 | -12,250.66 | -8,812.85 |
| EPS Basic Continuous Ops | 16,402.62 | -151.51 | -2,530.75 | -14,184.67 | 27,769.71 |
| EPS Diluted Total Ops | 15,986.17 | -153.20 | -4,049.20 | -12,250.66 | -8,812.85 |
| EPS Diluted Continuous Ops | 16,402.62 | -151.51 | -2,530.75 | -14,184.67 | 27,494.48 |
| EPS Diluted Before Non-Recurring Items | N/A | -150.06 | -4,033.61 | N/A | N/A |
| EBITDA(a) | $-3,199 | $-5,628 | $-2,527 | $-3,544 | $-5,378 |